Evidence map›Paper›PMID 40707833›Full record

ReviewJournal of hematopathology2025

Plasmablastic plasmacytoma followed by a plasmacytic plasma cell myeloma: insights into discordant extramedullary transformation-a case report and literature review.

Mitra Abdolahi, Osvaldo Padilla, Sandeep S Dave, Devang Thakkar, Reza Nejati

Abstract readCase ReportsReview
PubMed Publisher
In one paragraph

Review in Journal of hematopathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mitra AbdolahiDepartment of Pathology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA, 19111, USA.
Osvaldo PadillaDepartment of Pathology, PL Foster School of Medicine, Texas Tech University Health Sciences Center, 4625 Alberta Ave, El Paso, TX, 79905, USA.
Sandeep S DaveDepartment of Medicine and Center for Genomic and Computational Biology, Duke Cancer Institute, Duke University, Durham, NC, 27707, USA.
Devang ThakkarDepartment of Medicine and Center for Genomic and Computational Biology, Duke Cancer Institute, Duke University, Durham, NC, 27707, USA.
Reza NejatiDepartment of Pathology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA, 19111, USA. Reza.Nejati@fccc.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plasma cell neoplasms encompass a spectrum of disorders characterized by the clonal proliferation of plasma cells. Plasmablastic transformation in these neoplasms poses diagnostic and clinical challenges due to its aggressive nature and morphological overlap with other malignancies, including plasmablastic lymphoma (PBL). We report a case of discordant extramedullary plasmablastic transformation in a 55-year-old HIV-negative female presenting with an oral lesion diagnosed as plasmablastic plasmacytoma. Initial imaging indicated localized disease without systemic involvement. Despite undergoing chemotherapy and achieving a partial response, the patient developed osteolytic lesions 2 years later. Subsequent pathology evaluation confirmed mature plasma cell myeloma (PCM) morphology. Whole exome sequencing (WES) and whole RNA expression analysis revealed shared mutations (PTPN13, KRAS, LTK) and a MYC::BMP6 translocation in both lesions, supporting a clonal relationship. Additionally, the oral plasmablastic lesion revealed a KLHL6 mutation and an extra MYC::IGL translocation, which were absent in the tibial lesion. The KLHL6 mutation has not been previously reported in studies of discordant extramedullary plasmacytoma with plasmablastic transformation. This case highlights the diagnostic complexity of plasmablastic plasmacytoma presenting as the initial manifestation of plasma cell myeloma. It underscores the necessity of a thorough evaluation, including bone marrow biopsy, to accurately differentiate plasmablastic transformation from PBL and ensure accurate diagnosis and appropriate management.

Indexed as

Cell Transformation, NeoplasticMultiple MyelomaPlasmacytomaFemaleHumansMiddle AgedMutationExtramedullary plasmacytomaMYC translocationPlasmablastic plasmacytomaPlasmablastic transformationPlasma cell myeloma

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.